Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeShare-based CompensationShare-based CompensationShares Issued
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences, Inc. (RNA) Amortizatization of Intangibles (2020 - 2025)

Avidity Biosciences' Amortizatization of Intangibles history spans 6 years, with the latest figure at -$6.8 million for Q4 2025.

  • For Q4 2025, Amortizatization of Intangibles fell 135.81% year-over-year to -$6.8 million; the TTM value through Dec 2025 reached $4.2 million, down 80.22%, while the annual FY2025 figure was $4.2 million, 80.22% down from the prior year.
  • Amortizatization of Intangibles reached -$6.8 million in Q4 2025 per RNA's latest filing, down from $9.4 million in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $19.0 million in Q4 2024 to a low of -$6.8 million in Q4 2025.
  • Average Amortizatization of Intangibles over 5 years is $2.0 million, with a median of $755000.0 recorded in 2022.
  • Peak YoY movement for Amortizatization of Intangibles: tumbled 922.22% in 2021, then surged 5420.69% in 2022.
  • A 5-year view of Amortizatization of Intangibles shows it stood at -$92000.0 in 2021, then surged by 840.22% to $681000.0 in 2022, then soared by 375.33% to $3.2 million in 2023, then soared by 486.16% to $19.0 million in 2024, then crashed by 135.81% to -$6.8 million in 2025.
  • Per Business Quant, the three most recent readings for RNA's Amortizatization of Intangibles are -$6.8 million (Q4 2025), $9.4 million (Q3 2025), and $821000.0 (Q2 2025).